Weerawat Manosuthi, Sumet Ongwandee, Sorakij Bhakeecheep et al.
1
Welburn S. C., Beange I. et al
1
Whitmee S., Haines A. et al.
1
WHO
1
WHO Regional Office for Africa
1
Wiley Online Library
1
Wirth, James P.
1
WONCA
1
World Bank
1
World Health Organisation
1
World Health Organization ( WHO), Regional Office for South-East-Asia
1
World Health Organization (Europe)
1
World Health Organization (Pacific Region)
1
World Health Organization (South-East-Asia)
1
World Health Organization (WHO) - Regional Office for South-East Asia
1
World Health Organization (WHO), Alliance for Health Policy and Systems Research
1
World Health Organization South-East Asia Region
1
World Health Organization WHO (Africa)
1
World Health Organization WHO, Regional Office for Europe
1
World Health Organization WHO, Food and Agriculture Organization of the United Nations FAO
1
World Health Organization WHO, Regional Office for Europe, et al.
1
World Health Organization, TB HIV working group, Stop TB Partnership
1
World Health Organization, WFN
1
World Heart Federation
1
Xiaoxu Wu, Yongmei Lu, Sen Zhou et al.
1
Y. Cheng
1
Y. M. F. Moreno
1
Y. Ono
1
Yaria, J.
1
Yolaine Glèlè-Ahanhanzo, Alphonse Kpozèhouen, Noël Moussiliou Paraïso, Patrick Makoutodé, Chabi O. Alphonse Biaou, Eric Remacle, Edgard-Marius Ouendo, Alain Levêque
1
Yuyun, M.F.
1
Z. Qiao
1
Zipper, S.
1
Александрович Ю.С., Алексеева Е.И., Бакрадзе М.Д., et al.
1
Е.А. Катунина, Ю.Н. Бездольный
1
Министерство здравоохранения Российской Федерации
1
Российский государственный медицинский университет им. Н.И. Пирогова Кафедра неврологии и нейрохирургии лечебного факультета д.м.н., доцент Е.А. Катунина, к.м.н. Ю.Н. Бездольный
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...nterventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.more
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class...é dans le DSM et la CIM au sein des troubles habituellement
diagnostiqués dans la prime enfance, l’enfance ou l’adolescence (Krain et al, 2007).more
To understand the mental health treatment gap in the Region of the Americas by examining the prevalence of mental health disorders, use of mental health services, and the global burden of disease.
Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diab...etes and alcohol-use disorders. Mental disorders share common features with other NCDs, including many underlying causes and overarching consequences, their high interdependency and tendency to co-occur, and their predilection to being best managed using integrated approaches.more
This study complements the growing amount of research on the psychosocial impact of war on chil-dren in Sierra Leone by examining local perceptions of child mental health, formal and informal care systems, help-seeking behaviour and stigma
Yoder et al. Int J Ment Health Syst (2016) 10:48 DOI 10.11...86/s13033-016-0080-8more